European shares gain ahead of big week for central banks



(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)

Dec 13 (Reuters) - European shares inched higher on Monday, lifted by economically sensitive sectors, ahead of monetary policy decisions by some of the world's largest central banks that could potentially include an early end to U.S. policy stimulus.

The pan-European benchmark STOXX 600 .STOXX was up 0.3% at 476.88 points, as of 0826 GMT. Asian stocks tracked Wall Street gains after U.S. inflation data, which was well within market expectations, sent the S&P 500 .SPX to all-time high on Friday.

Investor focus is on monetary policy decisions expected to be taken by the European Central Bank (ECB), the U.S. Federal Reserve, the Bank of England, and the Bank of Japan this week.

The ECB is set to halve the amount of assets it buys each month from April, according to a Reuters poll, which judged that a reprieve from high euro zone inflation by late 2022 means a rate hike is years away.

Miners .SXPP offered the biggest boost, jumping 1.6% after top copper consumer China pledged to focus on economic stability and keep growth within a reasonable range next year.

Vifor Pharma VIFN.S jumped 14% after Australian biopharma giant CSL CSL.AX confirmed it was in talks to buy the Swiss drugmaker in a deal reported by media to be worth about $7.2 billion.

Shares of UniCredit CRDI.MI advanced 1.7% after the lender announced it wants to grow its domestic footprint and could consider tie-ups in Italy and beyond, but has no interest in the country's biggest insurer Generali GASI.MI and its top shareholder Mediobanca MDBI.MI .

Air France KLM AIRF.PA inched up 0.3% after saying it redeemed 500 million euros from an earlier French state loan issued to help the carrier cope with the pandemic, and could also raise new equity.


Reporting by Anisha Sircar in Bengaluru; Editing by Sherry Jacob-Phillips

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.